Austin, Texas-based Monebo Technologies announced that its CardioBelt Electrode System received clearance by the U.S. Food and Drug Administration. The system is an electrocardiogram device worn around the chest that is used for remote patient monitoring. Data then is transferred wirelessly to a communication device, such as a hand-held radio or smartphone, according to the company.